 | Up a level |
Didden, EM; Ruffieux, Y; Hummel, N; Efthimiou, O; Reichenbach, S; Gsteiger, Sandro; Finckh, Axel; Fletcher, Christine; Salanti, G; Egger, Matthias; Work Package, IMI GetReal (2018). Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis. Medical decision making, 38(6), pp. 719-729. Sage Publications 10.1177/0272989X18775975
Kilcher, Gablu Roman; Hummel, Noemi; Didden, Eva-Maria; Egger, Matthias; Reichenbach, Stephan (2018). Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries. Rheumatology, 57(2), pp. 354-369. Oxford University Press 10.1093/rheumatology/kex394
Panayidou, Klea; Gsteiger, Sandro; Egger, Matthias; Kilcher, Gablu; Carreras, Máximo; Efthimiou, Orestis; Debray, Thomas P A; Trelle, Sven; Hummel, Noemi (2016). GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world. Research Synthesis Methods, 7(3), pp. 264-277. Wiley 10.1002/jrsm.1202
Debray, Thomas P A; Moons, Karel G M; van Valkenhoef, Gert; Efthimiou, Orestis; Hummel, Noemi; Groenwold, Rolf H H; Reitsma, Johannes B (2015). Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Research Synthesis Methods, 6(4), pp. 293-309. Wiley 10.1002/jrsm.1160
Kilcher, G; Didden, E; Hummel, N; Egger, M (November 2015). Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in The Real World: Systematic Review. Value in health, 18(7), A657-A658. Elsevier 10.1016/j.jval.2015.09.2379
Hummel, N; Gsteiger, S (November 2015). Disease Progression In Rheumatoid Arthritis: Key Element for Cost-Effectiveness Modelling. Value in health, 18(7), A704-A705. Elsevier 10.1016/j.jval.2015.09.2642
